CHAQ
Chardan Healthcare Acquisition 2 Corp.
Set alert
- Open
- 9.35
- Prev close
- 8.41
- Mkt cap
- 90.65M
- Vol
- 242.66K
- Avg vol
- 44.72K
- EPS
- -0.061
- P/E
- -137.87
- Div yield
- 0.00%
More statistics
- Low
- 8.10
- High
- 9.25
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.34
- Inst. own
- 58.73%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 9.92
- 200-d avg
- 10.04
- 1y target
- 0.00
News
5 years ago businesswire.com
Renovacor, Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange
PHILADELPHIA--(BUSINESS WIRE)--Renovacor, Inc. Closes its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange.
5 years ago prnewswire.com
Chardan Healthcare Acquisition 2 Corp. Announces Stockholder Approval Of Business Combination With Renovacor, Inc.
NEW YORK, Sept. 1, 2021 /PRNewswire/ -- Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) ("CHAQ"), a special purpose acquisition company sponsored by Chardan Capital Markets ("Chardan"), today…
5 years ago prnewswire.com
Chardan Healthcare Acquisition 2 Corp. Announces Renovacor's Appointment of Matt Killeen, Ph.D., as Chief Scientific Officer
NEW YORK, Aug. 25, 2021 /PRNewswire/ -- Renovacor, Inc. ("Renovacor"), an early–stage biotechnology company developing adeno-associated virus (AAV)–based gene therapies for devastating cardiovascular…
5 years ago globenewswire.com
Renovacor Announces the Appointment of Jiwen Zhang, Ph.D., as Senior Vice President, Regulatory Affairs and Quality Assurance
Dr. Zhang has over 20 years of experience in regulatory affairs, with over a decade specifically in the field of cell and gene therapy Dr. Zhang has over 20 years of experience in regulatory affairs,…
5 years ago prnewswire.com
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Chardan Healthcare Acquisition 2 Corp. - CHAQ
NEW YORK, March 27, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities…
6 years ago seekingalpha.com
U.S. IPO Weekly Recap: Solar Technology Shines In A 9-IPO Week
Nine IPOs and five SPACs went public this past week, and one IPO postponed. New filing activity continued to pump the brakes as we near the election, with just one new IPO filing.
6 years ago seekingalpha.com
U.S. IPO Weekly Recap: Health And Tech Dominate The Calendar In An 11 IPO Week
September activity remained high as 11 IPOs and eight SPACs went public this past week. The IPO market shows no signs of slowing with eight IPOs and 18 SPACS submitting initial filings.
7 years ago fool.com
Kamada Ltd. (KMDA) Q2 2019 Earnings Call Transcript | The Motley Fool
KMDA earnings call for the period ending June 30, 2019.